Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 2Lennox Gastaut Syndrome 2Epilepsies, Myoclonic 2Seizures 1Neoplasms 1Liver Cirrhosis 1Anxiety Disorders 1

Interventions

Surveys and Questionnaires 2Timbre Perception 1Palliative Care 1Meditation 1Interviews as Topic 1Forest Therapy 1Educational Status 1Cannabidiol 1Art Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Anxiety Disorders × Cannabidiol × Clear all
NCT04482244 2025-07-29

RCT of CBD for Anxiety in Advanced Breast Cancer

Dana-Farber Cancer Institute

Phase 2 Active not recruiting
60 enrolled 11 charts

Anxiety Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡